Glenmark Pharmaceuticals has received certificate of compliance for Baddi manufacturing facility from European regulator, SUKL (State Institute for Drug control), Czech Republic. This certificate complies with the principles and guidelines of good manufacturing practice laid down in the directive 2003/94/EC which stipulates the requirements to fulfil GMP recommendations of WHO.
Baddi manufacturing unit of the company was inspected by the leading European regulator, SUKL, Czech Republic in the week of October 21, 2019.
Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1528.20 |
Dr. Reddys Lab | 5872.35 |
Cipla | 1405.95 |
Zydus Lifesciences | 997.45 |
Lupin | 1638.40 |
View more.. |